Invasive fungal disease in PICU: Epidemiology and risk factors

Annals of Intensive Care

Volumn 2, Issue 1, 2012, Pages 1-8

  Brissaud, Olivier ^a   Guichoux, Julie ^a   Harambat, Jerome ^a   Tandonnet, Olivier ^a   Zaoutis, Theoklis ^b  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CORTICOSTEROID; IMIPENEM; MEROPENEM; METRONIDAZOLE; SULTAMICILLIN; TIMENTIN; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ANEMIA; APLASTIC ANEMIA; ARTERY CATHETER; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIDULANS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD SAMPLING; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CENTRAL VENOUS CATHETER; CHILD HOSPITALIZATION; CHILDHOOD CANCER; CHILDHOOD DISEASE; CHRONIC MYELOID LEUKEMIA; DISEASE SEVERITY; FUNGAL STRAIN; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HOSPITAL COST; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE UNIT; INVASIVE ASPERGILLOSIS; INVASIVE CANDIDIASIS; MORTALITY; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; TOTAL PARENTERAL NUTRITION; UNITED STATES;

EID: 84859813359     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/2110-5820-2-6     Document Type: Article

References (37)

1. Burgos A, Zaoutis TE, Dvorak CC, Hoffman JA, Knapp KM, Nania JJ, et al: Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 2008, 121:e1286-e1294.
2. Neu N, Malik M, Lunding A, Whittier S, Alba L, Kubin C, et al: Epidemiology of candidemia at a children's hospital, 2002 to 2006. Pediatr Infect Dis J 2009, 28:806-809.
3. Zaoutis TE, Prasad PA, Localio AR, Coffin SE, Bell LM, Walsh TJ, et al: Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis 2010, 51:e38-e45.
4. Filioti J, Spiroglou K, Panteliadis CP, Roilides E: Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome. Intensive Care Med 2007, 33:1272-1283.
5. Steinbach WJ: Epidemiology of Invasive Fungal Infections in Neonates and Children. Clin Microbiol Infect 2010.
6. Zaoutis T: Candidemia in children. Curr Med Res Opin 2010, 26:1761-1768.
7. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C: The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005, 41:1232-1239.
8. Richards MJ, Edwards JR, Culver DH, Gaynes RP: Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1999, 103:e39.
9. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, et al: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:503-535.
10. Mor M, Gilad G, Kornreich L, Fisher S, Yaniv I, Levy I: Invasive fungal infections in pediatric oncology. Pediatr Blood Cancer 2011, 56:1092-1097.
11. Posfay-Barbe KM, Zerr DM, Pittet D: Infection control in paediatrics. Lancet Infect Dis 2008, 8:19-31.
12. Blyth CC, Palasanthiran P, O'Brien TA: Antifungal therapy in children with invasive fungal infections: a systematic review. Pediatrics 2007, 119:772-784.
13. Branger B: Enquête de prévalence nationale 2001 des infections nosocomiales chez les nouveau-nés et des enfants et adolescents de moins de 18 ans. Arch Pediatr 2005, 12:1085-1093.
14. Grisaru-Soen G, Sweed Y, Lerner-Geva L, Hirsh-Yechezkel G, Boyko V, Vardi A, et al: Nosocomial bloodstream infections in a pediatric intensive care unit: 3-year survey. Med Sci Monit 2007, 13:CR251-CR257.
15. Dutta A, Palazzi DL: Candida non-albicans versus Candida Albicans Fungemia in the non-neonatal pediatric population. Pediatr Infect Dis J 2011.
16. Singhi S, Rao DS, Chakrabarti A: Candida colonization and candidemia in a pediatric intensive care unit. Pediatr Crit Care Med 2008, 9:91-95.
17. Mahieu LM, Van Gasse N, Wildemeersch D, Jansens H, Ieven M: Number of sites of perinatal Candida colonization and neutropenia are associated with nosocomial candidemia in the neonatal intensive care unit patient. Pediatr Crit Care Med 2010, 11:240-245.
18. Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN: Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009). Diagn Microbiol Infect Dis 2010, 68:278-283.
19. Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE: Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J 2004, 23:635-641.
20. Rex JH, Sobel JD: Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 2001, 32:1191-1200.
21. Eggimann P, Garbino J, Pittet D: Management of Candida species infections in critically ill patients. Lancet Infect Dis 2003, 3:772-785.
22. Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, et al: A bedside scoring system (Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006, 34:730-737.
23. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994, 220:751-758.
24. Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, Dromer F: Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother 2011, 55:532-538.
25. Zaoutis TE, Coffin SE, Chu JH, Heydon K, Zhao H, Greves HM, et al: Risk factors for mortality in children with candidemia. Pediatr Infect Dis J 2005, 24:736-739.
26. Fujitani S, Ricardo-Dukelow M, Kamiya T, Sullivan L, Low L: Ethnicity and other possible risk factors for candidemia at 3 tertiary care university hospitals in Hawaii. Infect Control Hosp Epidemiol 2006, 27:1261-1263.
27. Sung L: Invasive fungal infections in children with cancer. J Pediatr 2010, 156 S68-S73.
28. Segal BH: Aspergillosis. N Engl J Med 2009, 360:1870-1884.
29. Crassard N, Hadden H, Piens MA, Pondarre C, Hadden R, Galambrun C, et al: Invasive aspergillosis in a paediatric haematology department: a 15-year review. Mycoses 2008, 51:109-116.
30. Abbasi S, Shenep JL, Hughes WT, Flynn PM: Aspergillosis in children with cancer: A 34-year experience. Clin Infect Dis 1999, 29:1210-1219
31. Zaoutis TE, Heydon K, Chu JH, Walsh TJ, Steinbach WJ: Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 2006, 117:e711-e716
32. Groll AH, Kurz M, Schneider W, Witt V, Schmidt H, Schneider M, et al: Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival. Mycoses 1999, 42431-442.
33. Walmsley S, Devi S, King S, Schneider R, Richardson S, Ford-Jones L: Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J 1993, 12:673-682.
34. Steinbach WJ: Invasive aspergillosis in pediatric patients. Curr Med Res Opin 2010, 26:1779-1787.
35. Dotis J, Iosifidis E, Roilides E: Central nervous system aspergillosis in children: a systematic review of reported cases. Int J Infect Dis 2007, 11:381-393.
36. Muller FM, Trusen A, Weig M: Clinical manifestations and diagnosis of invasive aspergillosis in immunocompromised children. Eur J Pediatr 2002, 161:563-574.
37. Lin SJ, Schranz J, Teutsch SM: Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001, 32:358-366